Verve Therapeutics Inc
NASDAQ:VERV
| Market Cap (Intraday) | 483.88M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $6.89 |
| 50-Day MA | $11.64 |
| 200-Day MA | $13.12 |
Verve Therapeutics Inc Stock, NASDAQ:VERV
201 Brookline Avenue, Suite 601, Boston, Massachusetts 02215
United States of America
Phone: +1.617.603.0070
Number of Employees: 255
Description
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.